SLC16A1 and cancer: This effect was diminished when we tested cancer cells with impaired ability to metabolize glutamine or lactate (by siRNA against GLS or MCT1; Fig. 5f and Supplementary Fig. 4b), indicating the growth-promoting effect was mediated by glutamine and lactate.